Compounds of formula (I) in free or salt or solvate form, wherein T has themeaning as indicated in the specification, are useful for treating conditionsthat are prevented or alleviated by activation of the .beta.2-adrenoreceptor.Pharmaceutical compositions that contain the compounds and a process forpreparing the compounds are also described.